INTRODUCTION
Arterial remodeling in response to flow changes is mediated in part via luminal wall shear stress (WSS) transduced through endothelial cells [1, 2] . Luminal diameter varies with changes in flow to maintain WSS within a narrow physiological range [3, 4] . Diameter changes are mediated acutely via smooth muscle tone (involving nitric oxide production and release [5] ) and, in more chronic conditions, extracellular matrix degradation, turnover, and remodeling [6] .
Matrix metalloproteinase (MMP) activity may mediate chronic flow-induced arterial wall remodeling [7] . MMPs are Zn 2ϩ -dependent endopeptidases active against collagen and elastin. Smooth muscle and endothelial cells, fibroblasts, and any inflammatory cells within the arterial wall produce MMPs. To date, of the more than 20 distinct MMPs described, 72-kDa gelatinase A (MMP-2) and 92-kDa gelatinase B (MMP-9) have been studied most extensively with respect to their role in arterial remodeling [8 -10] .
RS 113,456 (Roche Bioscience) is a specific, though nonselective, competitive MMP inhibitor with known in vitro activity against at least eight human and three rodent MMPs. Treatment with RS 113,456 at 25 mg/ kg/day po b.i.d. limited flow-mediated aortic and ipsilateral common iliac arterial enlargement in the rat femoral AVF model [7] . Although diameter enlargement was reduced in AVF rats treated with RS 113,456, the mechanism of action remained uncertain. Adverse hemodynamic or toxic effects not seen at the single dose studied, of RS 113,456 may have limited enlargement rather than or in addition to competitive inhibition of MMP activity. Individual MMP messenger expression or enzymatic activity during flowmediated arterial enlargement was also not determined in this experiment.
To further validate the effect of MMP inhibition on flow-mediated arterial enlargement, we designed a dose-response experiment in the rat AVF model to control for possible hemodynamic or toxic effects of RS 113,456. To examine the individual expression and activity of MMP-2 and MMP-9 in arterial enlargement, an additional cohort of AVF rats were sacrificed in a time course fashion and aortas were assayed via reverse transcription and the polymerase chain reaction (RT-PCR). Gelatin zymography was also performed on iliac arteries to assay gelatinolytic activity of MMP-2 and MMP-9. A third cohort of rats had tissue harvested for histological examination.
METHODS

Ethical and Anesthetic Considerations
Eight-six male Sprague-Dawley rats (weight, 350 -450 g) were used for this experiment. Intraperitoneal sodium pentobarbital (Abbott Labs, Chicago, IL) 25-50 mg was used for anesthesia. Animals recovered from the operation in separate cages with free access to food and water. All experimental procedures were approved by the Animal Care and Use Committee of Stanford University and were in accordance with the Guide for the Care and Use of Laboratory Animals, HHS Publication 86-23, revised 1985.
AVF Creation
Clean surgical technique, involving sterilization of instruments and scrubbing of the operative area, was used for all procedures. After intravenous injection of 100 U/kg beef lung heparin (prophylaxis against thrombosis) into all rats (Upjohn Co., Kalamazoo, MI), a left common femoral AVF was created as previously described [7] . Briefly, through a longitudinal groin incision at 25ϫ magnification the common femoral artery (CFA) and vein (CFV) were isolated and controlled. The CFV was ligated distally and divided. A 2.5 to 3.0-mm longitudinal arteriotomy was made in the CFA, and the arteriovenous anastomosis was created with running 8-O nylon suture in an end-to-side fashion. Patency following AVF creation was confirmed by the presence of pulsatile, oxygenated CFV blood flow. Ipsilateral common iliac flow has been shown to increase fourfold or more following AVF creation in this model [8] . Following completion of the fistula, the wound was closed with stainless-steel clips and the rats were recovered.
Prior to AVF construction, the animals were divided into two cohorts: (1) the dose-response cohort (52 rats) and (2) the time course cohort (34 rats).
Dose-Response Cohort
RS 113,456/vehicle administration. Two days prior to AVF construction, rats in the dose-response cohort were assigned in a random fashion into one of four different groups based on treatment with RS 113,456 in vehicle or vehicle alone. Rats in the vehicle group served as controls and received a solution consisting of 0.15 M NaCl, 0.4% Tween 80 (w/w), 0.9% benzyl alcohol (v/v), and 0.5% carboxymethylcellulose (w/w), pH 7.4, 0.5 ml by gastric intubation b.i.d. for a total volume of 1 ml/day. Rats in the treatment groups received either 12.5, 25, or 37.5 mg/kg RS 113,456 in 0.5 ml vehicle b.i.d. for total doses of 25, 50, or 75 mg/kg per day, respectively.
Serial measurements. Heart rate and blood pressure measurements were recorded with a noninvasive tail pressure plethysmographic system (IITC Inc/Life Science Instruments, Woodland Hills, CA). Baseline heart rate, blood pressure, and weight were recorded 2 days prior to fistula creation (POD Ϫ2). Repeated measurements were obtained on PODs 0 (preop), 7, 14, and 21 (prior to sacrifice). Physiological measurements were obtained without knowledge of randomization category.
Diameter measurement. On POD 21, rats were anesthetized and AVF patency was confirmed through left femoral redissection and direct inspection. Rats found to have occluded AVFs were sacrificed by anesthetic overdose and excluded from further analysis. The common carotid artery was exposed and cannulated with a pressure transducer catheter (Millar Mikro-tip; Millar Instruments, Houston, TX) connected to an amplifier (Crystal Biotech, Hopkinton, MA) for continuous intraarterial pressure monitoring during diameter measurement. Direct measurements of the aorta and iliac arteries were obtained at laparotomy via microcaliper placement (L.S. Starrett, Athol, MA). A photographic record at 25ϫ magnification with an internal scale was obtained for documentation and ex vivo measurement. All measurements were taken within 2 mm of the aortic bifurcation and were performed without knowledge of randomization category.
Histological analysis. Six separate rats were later randomized into one of three groups. These rats received either (1) fistula with vehicle dosing as described above, (2) fistula and 50 mg/kg/d RS 113456 as described above, or (3) no fistula and no drug to serve as a control. After 21 days, all rats underwent laparotomy for exposure of the aorta and iliac arteries. The rats were then sacrificed via anesthetic overdose and the vessels were pressure-perfused fixed at 110 mm Hg with 10% phosphate-buffered formalin. The iliac arteries were harvested and mounted in epoxy for sectioning and examination with light microscopy.
Time Course Cohort
Tissue harvest. Six to eight AVF rats in the time course cohort were sacrificed at 0 (no fistula), 3, 7, 14, and 21 days following fistula creation. AVF patency was confirmed and aortic measurements obtained prior to harvest in the manner described for the doseresponse cohort. The infrarenal aorta and left and right iliac arteries were dissected free of surrounding connective tissue, removed, and immediately snap-frozen in liquid nitrogen. The rats were subsequently sacrificed via anesthetic overdose.
Primer design and RNA extraction. Primers were constructed using published cDNA sequences for rat GAPDH, MMP-9, and MMP-2. PCR primers (including nested primers) were chosen using the oligonucleotide analysis program OLIGO 4.0 (National Biosciences). The primer sequences and expected product lengths are listed in Table 1 . Total RNA was extracted from the aortic specimens using the RNAgents Total RNA Isolation System (Promega, Madison, WI). Following incubation, 60 l sodium acetate was added, followed by phenol/chloroform extraction and isopropanol precipita-tion. RNA quality and quantity were confirmed via spectrophotometric analysis (A 260 /A 280 ). RNA with A 260 /A 280 Յ 1.6 was excluded from further analysis.
Reverse transcription and polymerase chain reaction. The SuperScript II RT-PCR System (Life Technologies, Grand Island, NY) was used to perform RT and PCR in the same tube. Reactions for MMP-2 and MMP-9 were each performed alongside GAPDH reactions for the same specimen. Equal amounts of RNA were present in each sample based on spectrophotometric analysis. Conditions were optimized to minimize transcription of any DNA contaminant. Each 50-l reaction contained a fixed amount of RNA (1 to 10 l, depending on optimal concentration), 1ϫ reaction buffer containing deoxynucleotide triphosphates, 200 nM of each primer (3Ј and 5Ј), 1.4 -2.5 mM Mg 2ϩ , and 1 l RT-Taq mix. RT and PCR were done on a PCR Gene Amp System (Perkin-Elmer, Foster City, CA). RT was run at 45°C for 15-25 min. Amplification was performed for 35 cycles (denaturation at 94°C for 15 s, annealing for 30 s at 55°-63°C, and extension at 72°C for 10 min).
Analysis. After PCR, equal volumes of product were run on 1.5% agarose gels and stained with 0.5 mg/ml ethidium bromide. Integrated density values (IDVs) were obtained for MMP-2, MMP-9, and GAPDH from each sample using standard gel imaging equipment (IS1000 Digital Imaging System, San Leandro, CA).
Gelatin zymography. MMP-2 and -9 activity in normal-and highflow iliac arteries was determined via zymography. Right and left iliac arteries harvested from time course rats were ground to a fine powder in liquid N 2 and homogenized in buffer [50 mM Tris-HCl (pH 7.5), 10 mM CaCl 2 , 2.0 M guanidine hydrochloride, 0.25% (w/w) Triton X-100] before 30 min incubation on ice and centrifugation at 4°C for 1 h. Supernatant was then dialyzed in 50 mM Tris-HCl (pH 7.5), 0.25% (w/w) Triton X-100, and 1 M ZnSO 4 for 18 h at 4°C. Equal aliquots (25 g) of each sample were loaded with sample buffer (Tris-glycine SDS) onto 10% gelatin gels and electrophoresed at 175 V for 1 h in Tris with glycine and SDS. The gel was incubated in renaturing buffer [Triton X-100 2.5% (v/v) in deionized distilled H 2 O] for 30 min and then transferred to a developing buffer [50 mM Tris, 0.2 M NaCl, 5 mM CaCl 2 , and 0.02% Brij 35 (w/v), pH 7.6] for 24 h at 37°C. Following a 1-h stain in Coomassie blue (0.5% Coomassie blue, 10% acetic acid, 30% methanol), the gel was destained in 10% acetic acid/30% methanol for 30 min. Gelatin degrading enzymes were identified by their ability to clear substrate at their respective molecular weights as determined by simultaneous electrophoresis of purified MMP-2 and MMP-9.
Statistical Analysis
Measurements within groups were compared using two-tailed, paired t tests, with significance determined at the 0.05 level. Single time-point measurements were compared between all groups with one-way analysis of variance, with significance determined at the 0.05 level. Pairwise comparisons were performed according to the Bonferroni-Dunn procedure. This procedure prevented multiplecomparison error when looking for differences between groups; a P value of Յ0.0083 was necessary to achieve statistical significance at the 95% confidence level. All analyses were performed on a personal computer with the StatView 4.5 software package (SAS Institute, Berkeley, CA).
RESULTS
Dose-Response Cohort
AVFs were created in a total of 52 rats. Eight died from either bleeding or esophageal perforation prior to 21 days. At 21 days, AVFs in four rats were occluded, and these animals were excluded from further analy- Fig. 1 ). Left common iliac artery external diameter for rats receiving 50 mg/kg/day (1.61 Ϯ 0.2 mm) or 75 (1.54 Ϯ 0.1 mm) mg/kg/day was significantly smaller than the diameters measured in rats receiving 25 mg/kg/day (1.86 Ϯ 0.2) or vehicle alone (1.95 Ϯ 0.1 mm). As expected, right iliac diameter did not vary among the dosage groups. Heart rate and blood pressure did not vary significantly between or within groups at any time following fistula creation (Fig. 2) . No difference in rate or extent of weight gain was noted between groups.
Histology
Light microscopic examination revealed adequate pressure-perfused fixation (Fig. 3) . In normal-flow iliac artery, adventitia was intact and fascicles of smooth muscle were evident in the medial layer. In comparison to samples taken from control animals, left iliac artery exposed to high flow demonstrated adventitial atrophy and significant thinning of the medial layer. Smooth muscle architecture between the elastic lamellae also appeared less well defined. There was also no inflammatory infiltrate in the media or adventitia of the high-flow arteries. No visible difference was noted in the high-flow left iliac arteries from animals treated with RS 113456 versus those treated with vehicle alone. There was no difference in medial thickness and the adventitia was equally thinned in the treated animals.
Time Course Cohort
Average AVF length was 2.96 Ϯ 0.1 mm, and did not vary among the time points. Similarly, intraarterial blood pressure measurements did not vary significantly between the groups at sacrifice. A stepwise increase in external aortic diameter was noted at each of the five time points following AVF creation (Fig. 4) with flow-mediated arterial enlargement. Aortic diameter at 21 days (2.28 Ϯ 0.4) was significantly larger than that noted at 0 (1.47 Ϯ 0.2) or 3 (1.53 Ϯ 0.2) days (P Ͻ 0.05). Left iliac artery diameter at 21 days (1.77 Ϯ 0.2) was significantly larger than that noted at 0 (1.08 Ϯ 0.2), 3 (1.16 Ϯ 0.2), or 7 (1.42 Ϯ 0.2) days (P Ͻ 0.05).
To normalize for varying amounts of RNA in each specimen and the efficiency of the reverse transcription reactions, MMP-2 and MMP-9 results were expressed as densitometric ratios to same-specimen GAPDH. Within the limits of our technique, there was no significant trend in MMP-9/GAPDH ratios noted at any time following AVF creation (Figs. 5, 6 ). In contrast, there was an upward trend in MMP-2/GAPDH ratios over the same period.
Gelatin zymography of left iliac arteries showed increased activity of MMP-2 and other multiple, unidentified bands with introduction of high flow. Peak activity appeared on POD 7 (Fig. 7) . Also, MMP-2 activity was higher at all time points following fistula creation in the high-flow left iliac relative to the normal-flow right iliac artery. MMP-9 activity in the high-flow left iliac artery remained constant over time.
FIG. 2.
Serial measurements for the dose-response cohort, including heart rate (measured in beats per minute), noninvasive mean arterial pressure (NIMAP) (measured in mm Hg), and weight (measured in grams).
SUMMARY AND DISCUSSION
In the rat femoral AVF model, increasing doses of the specific but nonselective competitive MMP inhibitor RS 113,456 limited flow-mediated aortic and left common iliac diameter enlargement in a stepwise, dose-dependent fashion over 21 days. Serving as an internal control, right common iliac diameter did not change significantly among any groups during the course of the experiment. Treatment with RS 113,456 did not decrease heart rate or blood pressure within or between dosage groups. No toxic effect of RS 113,456 was noted based on equal and positive weight gain between the vehicle and treatment groups.
Although not definitive, these data provide strong additional evidence that MMP involvement in extracellular matrix remodeling is an essential component of flow-mediated arterial enlargement.
There were gross histological differences between normal-and high-flow left iliac arteries. Typical medial and adventitial thinning was present, but no inflammatory infiltrates that might influence enlargement were observed. Although overall diameter of the vessel was significantly lower in rats that received an MMP inhibitor, no histological difference was apparent at the light microscopy level. Ultrastructural analysis was not performed.
In the time course experiment, a progressive increase in MMP-2/GAPDH ratio was noted during the 21 days following fistula creation. However, no change in the MMP-9/GAPDH ratio was noted, suggesting that MMP-2 and MMP-9 expression may be differentially regulated during flow-mediated arterial enlargement. RT-PCR is not well suited for quantitative comparison without the use of internal standards that control for differences in reaction kinetics, which are dependent on absolute RNA quantity. The steady increase in MMP-2/GAPDH ratio compared with the MMP-9/GAPDH ratio through all time points does, however, suggest that these MMPs may be differentially regulated in this model, despite the uncertainties inherent in quantitation using RT-PCR.
Our finding of increased MMP-2 enzymatic activity parallels recent observations regarding flow-mediated MMP-2 activity in rabbit models. Using a carotid/ jugular fistula model, Tronc and associates found that doxycycline inhibited flow-mediated arterial enlargement at a single dose compared with placebo. Using gelatin zymography, they found increased MMP-2 activity in afferent carotid arteries from rabbits treated with placebo, though not in doxycycline-treated rabbits [8] . De Kleijn and associates also found MMP-2 zymographic activity to be increased in a similar untreated rabbit model [9] .
Using Northern blotting for MMP-2 mRNA, Bassiouny et al. reported no significant change in MMP-2 expression or activity following modest (1.5ϫ) in- creases in carotid artery flow 7 days following contralateral ligation [10] . A significant increase in MMP-2 was noted following balloon injury of the carotid prior to contralateral ligation in the same model. The failure of carotid arterial MMP-2 expression or activity to increase following contralateral carotid ligation alone may have been due to the modest increase in ipsilateral flow achieved in this model and/or the relatively short time frame chosen for tissue sampling (7 days vs 0, 3, 7, 14, and 21 days in our own experiment).
The role of MMP-9 activity in flow-mediated arterial enlargement is less certain. Where Tronc et al. found increased MMP-9 activity in afferent carotid arteries from rabbits treated with placebo using gelatin zymography (but not in doxycycline-treated rabbits), [8] . De Kleijn and associates noted no changes in MMP-9 activity in a similar, untreated rabbit model [9] . We found minimal difference in MMP-9 activity over time. Interestingly, in response to diminished flow following partial proximal carotid ligation, De Kleijn et al. found both MMP-2 and MMP-9 activity to be increased [9] .
The findings of Tronc and associates apparently contradict our findings and those of De Kleijn et al. [9] using the same methodology (gelatin zymography) in similar models. The use of zymography to determine in vivo MMP activity is problematic due to the uncertain binding of endogenous tissue inhibitors of metalloproteinases (TIMPs), which may be lost during tissue preparation [11] . Interrupted binding of exogenous inhibitor (doxycycline) present in the arterial tissue analyzed by Tronc and associates may also spuriously affect zymographic activity [8] . Despite these methodological concerns, it is possible that MMP-9 enzymatic activity is increased without an increase in expression. Since metalloproteinases are secreted into the extracellular matrix as proenzymes, activation of constitutive as opposed to inducible MMP-9 may account for the findings of increased zymographic activity versus stable expression of message as determined via RT-PCR in our own model [11] . The significance of speciesspecific differences between rabbit and rat AVF models is unknown.
Taken as a whole, these finding suggest that during flow-mediated arterial matrix remodeling and luminal enlargement, expression, and activity of individual MMPs are differentially regulated. While we examined the expression of MMPs (2 and 9) in response to a specific stimulus (increased flow) with one specific outcome (external diameter enlargement), there may well be characteristic patterns of MMP expression and activity involved in specific remodeling scenarios such as luminal enlargement or reduction, failure of the aortic wall, response to injury, or plaque instability or rupture.
In conclusion, nonselective MMP inhibition limits flow-mediated arterial enlargement in a dose-dependent fashion without apparent hemodynamic effect. Flow-mediated arterial enlargement may be associated with a specific expression profile of MMPs, with MMP-2 expression and activity in the aortic wall increasing from Days 3 to 21 following distal AVF cre- ation. Aortic MMP-9 expression and activity were not similarly affected. The role of MMP activity in arterial remodeling may hold considerable clinical significance in conditions such as poststenotic arterial dilation and abdominal aortic aneurysm formation in patients with unilateral above-knee amputations or other conditions producing chronic flow disturbances at the aortic bifurcation [12] .
